Pediatric Trial of Indoximod With Chemotherapy and Radiation for Relapsed Brain Tumors or Newly Diagnosed DIPG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Temozolomide
Related studies linked through entity extraction aliases.
Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
First-line Chemotherapy With Temozolomide Alone for Non-enhancing Adult Brainstem Gliomas, With a Diffuse Subtype and Showing Clinical and/or Radiological Infiltrative Pattern of Progression
- Status
- UNKNOWN
- Phase
- PHASE2
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas
- Status
- TERMINATED
- Phase
- PHASE2
Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma
- Status
- TERMINATED
- Phase
- PHASE2
BGB-290 and Temozolomide in Treating Patients With Recurrent Gliomas With IDH1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pan Tumor Rollover Study
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Clinical Trial Evaluating the Combination of Olaparib and Temozolomide for the Treatment of Advanced Uterine Leiomyosarcoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Early Temozolomide in Patients With High-Grade Gliomas in Rehabilitation
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
TTFields Together With Temozolomide and Radiotherapy in Patients With Newly Diagnosed GBM
- Status
- UNKNOWN
- Phase
- NA
HFSRT With Concurrent TMZ for Large BMs
- Status
- UNKNOWN
- Phase
- PHASE3
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
- Status
- COMPLETED
- Phase
- PHASE2
A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1
- Status
- COMPLETED
- Phase
- PHASE3
Trial in Low Grade Glioma Patients: Wait or Treat
- Status
- TERMINATED
- Phase
- PHASE3